Timeline | Returns | Volume |
---|---|---|
Daily | -4.30 | 95,810 |
Weekly | -4.40% | 30,21,831 |
Monthly | 10.83% | 78,47,859 |
Timeline | Daily | Weekly | Monthly |
---|---|---|---|
MANKIND | -4.30 | -4.40% | 10.83% |
Index | - | - | - |
Peer Avg. | - | 2.18% | 10.10% |
Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
---|---|---|---|---|---|---|
MANKIND | - | - | 32.67 | 19.27 | 23.49 | - |
Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
Peer Avg. | 38.60 | 4.35 | 13.48 | 12.96 | 16.49 | 0.78 |
Metrics | Sales Growth | Profit Growth | ROE | ROCE |
---|---|---|---|---|
FY '22-23 | 12.44% | -9.86% | 19.27% | 23.49% |
FY '21-22 | 25.22% | 12.37% | 26.72% | 33.96% |
FY '20-21 | 5.83% | 22.43% | 31.51% | 39.97% |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
FY '22-23 | 8,749.43 | 6,847.50 | 2,030.50 | 1,309.68 |
FY '21-22 | 7,781.56 | 5,791.01 | 2,186.58 | 1,452.96 |
FY '20-21 | 6,214.43 | 4,565.32 | 1,820.06 | 1,293.03 |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
MANKIND | 8,749.43 | 6,847.50 | 2,030.50 | 1,309.68 |
TORNTPHARM | 7,625.18 | 5,359.17 | 2,466.38 | 884.32 |
CIPLA | 17,427.56 | 13,488.35 | 4,433.43 | 2,624.43 |